← Back to Patent Explorer
US4883755A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of reendothelializing vascular linings

Assignee: Thomas Jefferson University
•
Filing: 1987-10-28
•
Granted: 1989-11-28
•
Expires: 2007-10-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for treating the vascular passage of a patient, damaged by procedures such as an endarterectomy which denude portions of the vascular passages of their endothelial cell linings, is disclosed. In this method, endothelial cells are isolated from the patient's own microvessels, the flow of blood through the patient's damaged vascular passage is interrupted, the endothelial cells isolated from the patient's microvessels are applied to the surface of the denuded portion of the patient's vascular passage in a density sufficient to provide covereage of at least about 50% of said denuded portion, and interruption of blood flow through the vascular passage is maintained for a period of time sufficient to allow the sodded cells to form an attachment to the vascular lining sufficient to withstand the shear created by resumed blood flow through the vascular passage.

Inventors

  • 👤 R. Anthony Carabasi
  • 👤 Bruce E. Jarrell
  • 👤 Stuart K. Williams

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 05:16
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/069; A; A61; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61F2/062; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/16; A61K35/44; A61L; A61L27/00; A61L27/36; A61L27/50; A61L27/507; A61P; A61P9/00; A61P9/14

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 111 words
A method of reendothelializing the vascular passage of a patient, the lining of which has been substantially denuded of endothelial cells, comprising (a) interrupting the flow of blood through said vascular passage, (b) applying to said denuded vascular lining uncultured endothelial cells retrieved from the microvessels of said patient in a density sufficient to provide coverage of at least about 50% of said denuded portion; and (c) maintaining the interruption of blood flow through said vascular passage for a period of time sufficient to allow 5 said applied cells to form an attachment to said vascular lining sufficient to withstand the shear created by resumed blood flow through said vascular passage.
Claim 2
Independent Claim 111 words
A method of reendothelializing the vascular passage of a patient, the lining of which has been substantially denuded of endothelial cells, comprising (a) interrupting the flow of blood through said vascular passage, (b) applying to said denuded vascular lining uncultured endothelial cells retrieved from the microvessels of said patient in a density sufficient to provide coverage of at least about 50% of said denuded portion; and (c) maintaining the interruption of blood flow through said vascular passage for a period of time sufficient to allow 5 said applied cells to form an attachment to said vascular lining sufficient to withstand the shear created by resumed blood flow through said vascular passage.
Claim 3
Dependent Claim 27 words
The method of claim 1 where said endothelial cells are applied in a density of at least about 1×10 5 cells per cm 2 of seeded surface.
Claim 4
Dependent Claim 27 words
The method of claim 1 where said endothelial cells are applied in a density sufficient to form a confluent layer of said cells on said vascular lining.
Claim 5
Dependent Claim 22 words
The method of claim 1 where said endothelial cells are applied to said vascular passage in a suspension of blood or plasma.
Claim 6
Dependent Claim 22 words
The method of claim 2 where said endothelial cells are applied to said vascular passage in a suspension of blood or plasma.
Claim 7
Dependent Claim 22 words
The method of claim 3 where said endothelial cells are applied to said vascular passage in a suspension of blood or plasma.
Claim 8
Dependent Claim 23 words
The method of claim 1 where said endothelial cells are applied to said vascular passage in a suspension of a non-gel-forming buffer solution.
Claim 9
Dependent Claim 23 words
The method of claim 2 where said endothelial cells are applied to said vascular passage in a suspension of a non-gel-forming buffer solution.
Claim 10
Dependent Claim 23 words
The method of claim 3 where said endothelial cells are applied to said vascular passage in a suspension of a non-gel-forming buffer solution.
Claim 11
Dependent Claim 18 words
The method of claim 1 where said endothelial cells are derived from the fat tissues of the patient.
Claim 12
Dependent Claim 18 words
The method of claim 4 where said endothelial cells are derived from the fat tissues of the patient.
Claim 13
Dependent Claim 18 words
The method of claim 7 where said endothelial cells are derived from the fat tissues of the patient.
Claim 14
Dependent Claim 26 words
The method of claim 1 where said endothelial cells are retrieved from said patient and applied to said patient's vascular lining during the sam operative procedure.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-11-27 1993-05-29 1993-11-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-11-27 1997-05-29 1997-11-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-11-27 2001-05-29 2001-11-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag